Latest Clinical News | Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Clinical

A promising new drug to combat serious inflammatory disease

A promising new drug to combat serious inflammatory disease

Performance of Masimo PVi® as a predictor of fluid responsiveness in mechanically ventilated ICU patients

Performance of Masimo PVi® as a predictor of fluid responsiveness in mechanically ventilated ICU patients

Patients with advanced metastatic breast cancer still have access to drug regardless of NICE decision

Patients with advanced metastatic breast cancer still have access to drug regardless of NICE decision

Biosimilar infliximab comparable to reference product and adalimumab in real-world study

Biosimilar infliximab comparable to reference product and adalimumab in real-world study

Rapid pollution increases may be as harmful to the heart as absolute levels

Rapid pollution increases may be as harmful to the heart as absolute levels

Rare medullary thyroid cancer treatment gets nod from NICE

Rare medullary thyroid cancer treatment gets nod from NICE

Cancer Research UK to invest £45 million in clinical trials

Cancer Research UK to invest £45 million in clinical trials

NHS rollout of innovative technology to accelerate diagnosis of atrial fibrillation

NHS rollout of innovative technology to accelerate diagnosis of atrial fibrillation

Radiometer helps enhance patient outcomes at the University of Leicester Hospitals NHS Trust

Radiometer helps enhance patient outcomes at the University of Leicester Hospitals NHS Trust

NICE approval for differentiated thyroid cancer drug

NICE approval for differentiated thyroid cancer drug

NICE recommends tivozanib as first-line treatment for advanced renal cell carcinoma

NICE recommends tivozanib as first-line treatment for advanced renal cell carcinoma

Marketing authorisation application for apalutamide submitted

Marketing authorisation application for apalutamide submitted